A Rare Adverse Event of Rhabdomyolysis Caused by Sacubitril/Valsartan
| العنوان: | A Rare Adverse Event of Rhabdomyolysis Caused by Sacubitril/Valsartan |
|---|---|
| المؤلفون: | Jeffrey Pradeep Raj, Pavani Nathala, Sajid Melvin George, Anantha R Vellipuram, Prashanth Rawla |
| المصدر: | Diseases Diseases, Vol 7, Iss 2, p 38 (2019) |
| بيانات النشر: | MDPI, 2019. |
| سنة النشر: | 2019 |
| مصطلحات موضوعية: | entresto, adverse drug reaction, lcsh:Medicine, Case Report, 030204 cardiovascular system & hematology, Pharmacology, Sacubitril, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Lactate dehydrogenase, Medicine, Adverse effect, biology, business.industry, lcsh:R, medicine.disease, Valsartan, chemistry, sacubitril/valsartan, biology.protein, rhabdomyolysis, Creatine kinase, business, Rhabdomyolysis, 030217 neurology & neurosurgery, Adverse drug reaction, Sacubitril, Valsartan, medicine.drug |
| الوصف: | Rhabdomyolysis is caused by extensive damage to skeletal muscles resulting in elevated creatine phosphokinase (CPK), Lactate dehydrogenase (LDH), and aspartate aminotransferase (AST), leading to life-threatening consequences like acute renal failure, cardiac arrhythmias, and hyperthermia. A variety of causes for muscle damage are known, and one of the most common is drug-induced. Statins and many other agents are known to induce muscle damage, but here we report Entresto™ (Sacubitril/Valsartan) induced rhabdomyolysis which has not been previously reported as solely responsible in the literature. |
| اللغة: | English |
| تدمد: | 2079-9721 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b0796578c599ba0cc241c5900ebbc02Test http://europepmc.org/articles/PMC6631059Test |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....0b0796578c599ba0cc241c5900ebbc02 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 20799721 |
|---|